CD274 and non-small cell lung carcinoma: Therefore, the aim of this research was to investigate and analyze the latest randomized control trial (RCT) evidence regarding the efficacy and safety of PD-L1 inhibitors alone with those of chemotherapy for treating advanced NSCLC.